Every trade that managers of ReposiTrak, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Technology sector. From 18 October 2025 to 18 October 2026, the disclosure feed for ReposiTrak, Inc. logged 28 filings by 4 insiders.
All open-market trades in the period are sales: 23 sales worth €976k, by 1 insider, with no purchase on record. Biggest ticket of the year: €100k, sold by Fields Randall K and made public on 21 October 2025.
Compared with its exchange (5,458 companies, median 22 filings), a count of 28 filings is above the norm. The full history, which starts in 2022, counts no purchases against 76 sales. For the fiscal year to 30 June 2026, the annual 10-K puts net income at 7.6 m USD.
Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
In the same sector, recent insider purchases at Gitlab Inc. and Baozun Inc. also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2025 · cache
25 of 101 declarations
ReposiTrak, Inc. (NYSE: TRAK) is a U.S.-listed technology company in the United States focused on SaaS-based supply chain management, compliance, and traceability solutions. The company is headquartered in Murray, Utah, at 5282 South Commerce Drive, Suite D292. Its corporate roots go back to Park City Group, Inc.; the business was rebranded as ReposiTrak in December 2023, and the common stock began trading on the NYSE in November 2023 after moving from Nasdaq. For international investors, this is best understood as a B2B software provider serving regulated supply-chain workflows rather than a consumer-facing tech brand.
ReposiTrak’s business model centers on a cloud platform that connects retailers, wholesalers, distributors, and their suppliers. The company helps customers manage programs such as scan-based trading, out-of-stock reduction, ordering and forecasting, and supplier risk management. A core part of the offering is compliance management, which supports supplier vetting, document collection, and regulatory-risk reduction across food and other supply chains. Another key product family is the ReposiTrak Traceability Network, built to support food traceability requirements in the U.S. by capturing and sharing key data elements across critical tracking events. In practical terms, this positions ReposiTrak at the intersection of software, food safety, and supply-chain governance.
From a competitive standpoint, ReposiTrak differentiates itself through specialization. Rather than competing broadly across all enterprise software categories, it focuses on traceability and compliance in food and adjacent supply chains, where regulatory complexity creates recurring demand for digital workflows. The platform model can also create network effects: as more suppliers and buyers join, the system becomes more valuable, which may help reinforce customer retention and raise switching costs. This specialization is important because the company operates in a niche where operational reliability and regulatory credibility matter more than flashy product features.
Geographically, ReposiTrak is primarily North American in its commercial footprint, but its technology is relevant to any supplier serving the U.S. food and retail market. Recent company updates indicate continued network expansion, with new supplier additions announced regularly, and recent quarterly reporting showing revenue growth and ongoing execution in the traceability roll-out. The company has also remained visible through SEC Form 4 insider transaction filings, which is consistent with a closely followed small-cap public company on NYSE. Overall, ReposiTrak appears to be a niche SaaS operator leveraging regulatory tailwinds, with its investment case tied to adoption of its traceability network, cross-sell into compliance modules, and sustained customer onboarding in the United States.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Jun 2026 | n.d. | 7.6 m USD | 0.39 USD | 10-K |
| Jun 2025 | n.d. | 7.0 m USD | 0.35 USD | 10-K |
| Jun 2024 | n.d. | 6.0 m USD | 0.29 USD | 10-K |
| Jun 2023 | n.d. | 5.6 m USD | 0.27 USD | 10-K |
| Jun 2022 | n.d. | 4.0 m USD | 0.18 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.